๐ฐ Bio Layer Interferometry News
Bio Layer Interferometry News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bio Layer Interferometry. Real-time updates on events, politics, business and more.
October 6, 2023
Dublin, Oct. 06, 2023 (GLOBE NEWSWIRE) -- The
September 25, 2023
WASHINGTON, Sept. 25, 2023 (GLOBE NEWSWIRE) -- As per Vantage Market Research, the Label-free Detection Market experiences significant growth primarily fueled by technological advancements, increasing collaboration between academic and industrial entities in drug discovery programs, and the remarkable sensitivity of label-free technologies. According to Vantage Market Research, the Global Label-free Detection Market is estimated to be valued at USD 1058.4 Million by 2030 and is expected to exhib
April 6, 2023
/PRNewswire/ -- The "Label-free Array System Market Size, Share & Trends Analysis Report By Type (Surface Plasmon Resonance, Bio-layer Interferometry, Cellular...
March 8, 2023
/PRNewswire/ -- The global label-free array system market size is expected to reach USD 799.59 million by 2030, expanding at a CAGR of 7.42% from 2023 to 2030,...
February 27, 2023
In this article, News-Medical talks to Sartorius about biosensing and bioprocessing in gene therapy, while also discussing the various products Sartorius produces in order to aid in this.
February 10, 2023
Sartoriusโ Octetยฎ range allows for unparalleled bio-layer interferometry (BLI) analysis, thus providing highly scalable throughput, flexibility, and more in biological analysis.
November 3, 2022
Growth during this market is driven by the introduction of technologically advanced products, a growing number of drug discovery programs through academic-industrial partnerships, and thus the
November 3, 2022
/PRNewswire/ -- Verified Market Research recently published a report, "Label-Free Detection Market" By Technology (Surface Plasmon Resonance, Bio-Layer...
August 1, 2022
01.08.2022 - DALLAS, Aug. 01, 2022 (GLOBE NEWSWIRE) - Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, presented new preclinical data on vaccine candidates targeting aberrant forms of the ... Seite 1
July 13, 2022
How molecular virologists are making strides in SARS-CoV-2 research, and the technology that powers their research